MMP-9 suppresses the proliferation of T-lymphocytes by shedding the interleukin-2 receptor-α from their surface and, like the MMPs -2 and -14, it impedes the reaction of T-lymphocytes against cancer cells by releasing TGF-β [56]. The gene discussed is TGFB1; the disease is cancer.